Michael Houghton

Michael Houghton
Name	Michael Houghton
Birth date	1949
Birth place	United Kingdom
Nationality	British-Canadian
Fields	Virology, Immunology, Molecular Biology
Workplaces	Chiron Corporation, GSK, University of Alberta, University of Cambridge
Known for	Discovery of hepatitis C virus
Awards	Nobel Prize in Physiology or Medicine, Gairdner Foundation International Award, Lasker–DeBakey Clinical Medical Research Award

Michael Houghton is a British-born virologist and molecular biologist noted for leading the team that discovered the hepatitis C virus. His work at industrial and academic institutions transformed blood screening, clinical virology, vaccine research, and public health practices related to transfusion-transmitted infections. Houghton's career spans collaborations with biotechnology companies, universities, and international health agencies.

Early life and education

Houghton was born in the United Kingdom and trained in molecular biology and microbiology, undertaking undergraduate and doctoral studies that connected him to institutions such as the University of Cambridge and research environments linked to King's College London and the University of Southampton. During his formative years he engaged with laboratories influenced by figures from the era of recombinant DNA research, including scientists associated with Frederick Sanger-era sequencing and contemporaries from the MRC Laboratory of Molecular Biology. His early mentors and collaborators included researchers who worked alongside groups at Imperial College London and other British research institutes, situating him within networks that later bridged to North American biotechnology firms and Canadian universities.

Research and career

Houghton's career combined industry and academia: he held positions at the biotechnology company Chiron Corporation and later at GlaxoSmithKline (GSK), before joining the University of Alberta and holding a chair at the University of Cambridge. His laboratory blended methods from molecular cloning pioneered in the 1970s with serological assay development used by transfusion services such as American Red Cross and national blood services including Canadian Blood Services and the National Health Service (England). Collaborations included partnerships with investigators from Stanford University, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and academic groups across Harvard University and Johns Hopkins University. Houghton led teams integrating immunology approaches from groups affiliated with Paul Ehrlich Institute and sequencing technologies influenced by companies such as Applied Biosystems.

Discovery of hepatitis C virus

In the late 1980s Houghton and colleagues at Chiron Corporation used molecular cloning and expression screening to identify a novel RNA virus responsible for non-A, non-B hepatitis, which had been a clinical and transfusion-transmitted problem documented by investigators from Baruch Blumberg-era hepatitis research and surveillance by the World Health Organization. The work followed epidemiological and virological studies from groups at Yale University and Mayo Clinic that had characterized post-transfusion hepatitis and unresolved cases after the identification of hepatitis A virus and hepatitis B virus. Using cDNA libraries and antibody screening informed by serology from blood banks and studies at the Centers for Disease Control and Prevention, Houghton's team identified sequences matching a flavivirus-like genome and developed assays that enabled blood screening campaigns by national services and agencies such as the Food and Drug Administration. The discovery prompted translational efforts linking virologists at University of California, San Francisco and clinicians at major transplant and hepatology centers including Mount Sinai Hospital and Mayo Clinic to characterize viral transmission, chronic infection, and liver disease progression, and to support antiviral drug development by pharmaceutical groups including Roche and Merck & Co..

Awards and honours

Houghton has received numerous honours for his discovery and subsequent contributions, including the Nobel Prize in Physiology or Medicine (shared), the Lasker–DeBakey Clinical Medical Research Award, and the Gairdner Foundation International Award. Other recognitions include prizes and fellowships from academies such as the Royal Society and the Canadian Academy of Health Sciences, honorary degrees from universities including University of Cambridge-affiliated colleges, and awards from public health organizations such as the World Health Organization. He has been elected to learned societies connected with Royal Society of Canada-level distinctions and received industry and academic prizes that reflect impact on transfusion medicine recognized by groups like the International Society for Infectious Diseases.

Personal life

Houghton has lived and worked in both the United Kingdom and Canada, maintaining ties to research communities in Cambridge and Edmonton. He has collaborated with clinicians and basic scientists across institutions such as Addenbrooke's Hospital and major North American hepatology centers. Details of his private life are kept private; he is known publicly for mentorship of scientists who have become faculty at institutions including McMaster University, University of Toronto, and University of British Columbia.

Selected publications

- Houghton M., et al., identification of hepatitis C virus by molecular cloning, published with co-authors affiliated to Chiron Corporation and collaborating academic centers. - Houghton M., translational studies on HCV diagnostics and blood screening implemented by American Red Cross and national blood services. - Reviews and research articles on hepatitis C virology, immunology, and vaccine efforts co-authored with investigators from University of Alberta, University of Cambridge, and international consortia including groups at World Health Organization-coordinated networks.

Category:British virologists Category:Nobel laureates in Physiology or Medicine